VIEWPOINTS


Viewpoints is a collection of opinion articles written by thought leaders and expert medical writers to draw attention to important issues and developments in oncology.


Will Patient-Reported Outcomes Be Included in Oncology Product Labeling?

Will Patient-Reported Outcomes Be Included in Oncology Product Labeling?

FDA, industry, and patients are talking, but agreement on how to include patient experiences in oncology product prescribing information remains elusive.

Bipolar Androgen Therapy Showing Promise for Castration Resistant Prostate Cancer

Bipolar Androgen Therapy Showing Promise for Castration Resistant Prostate Cancer

Bipolar androgen therapy (BAT) may benefit some men with asymptomatic CRPC who have a low to moderate metastatic burden.

Alternate Sunitinib Schedules May Benefit Some with Metastatic Renal Cell Carcinoma

Alternate Sunitinib Schedules May Benefit Some with Metastatic Renal Cell Carcinoma

Understanding optimal dosing regimens for renal cell carcinoma (RCC) could lead to improvements in dosing for all oral anticancer therapies.

Anti-PD-L1 Antibody Demonstrates Antitumor Activity in Triple-Negative Breast Cancer

Anti-PD-L1 Antibody Demonstrates Antitumor Activity in Triple-Negative Breast Cancer

Report from a phase 1 trial presented at the 2015 American Association for Cancer Research (AACR) annual meeting.

Sunitinib Showing Promise for Small-Cell Lung Cancer

Sunitinib Showing Promise for Small-Cell Lung Cancer

A phase II trial shows promise for patients with extensive small cell lung cancer who currently have limited treatment options.

After Breast Cancer, Many Women Express Desire for Genetic Testing

After Breast Cancer, Many Women Express Desire for Genetic Testing

A survey of ethnically diverse women treated for breast cancer has identified a "complete failure" among health care professionals to address concerns about genetic risk.

Adjuvant Ipilimumab Improves Recurrence-Free Survival of High-Risk Stage 3 Melanoma

Adjuvant Ipilimumab Improves Recurrence-Free Survival of High-Risk Stage 3 Melanoma

In patients with completely resected high-risk stage 3 melanoma, adjuvant ipilimumab significantly improved recurrence-free survival.

Too Many Axillary Lymph Node Evaluations for Ductal Carcinoma in Situ, Researchers Report

Too Many Axillary Lymph Node Evaluations for Ductal Carcinoma in Situ, Researchers Report

Too many patients are undergoing axillary lymph node evaluation with breast-conserving surgery (BCS) for ductal carcinoma in situ (DCIS).

Myth: Oncology Patients Demand Inappropriate Interventions

Myth: Oncology Patients Demand Inappropriate Interventions

According to a JAMA study, only 8.7% of patients with cancer requested medical interventions and only 11.4% of those were deemed inappropriate.

Early Radiation Postprostatectomy May Not Affect Erectile Function

Early Radiation Postprostatectomy May Not Affect Erectile Function

Research indicates the addition of the time from prostatectomy to radiation therapy was not significant for adverse events.

Cardiovascular Risk in Men with Prostate Cancer on GnRH Agonist Therapy

Cardiovascular Risk in Men with Prostate Cancer on GnRH Agonist Therapy

Study of prostate cancer patients finds that treatment with GnRH agonists, but not antiandrogens, increases risk of cardiovascular events and mortality.

Study Shows Inappropriate Medication Use Among Older Patients with Cancer

Study Shows Inappropriate Medication Use Among Older Patients with Cancer

A pharmacist-led medication assessment demonstrated a high prevalence of polypharmacy and potentially inappropriate medication use in seniors.

IP Chemotherapy Improves Survival in Advanced Ovarian Cancer, But Questions Remain

IP Chemotherapy Improves Survival in Advanced Ovarian Cancer, But Questions Remain

Treatment of ovarian cancer with IP chemo resulted in significant improvement in survival, but benefit could be explained by clinical factors.

Cancer Patients Should Avoid Fish, Fish Oil During Chemo, Researchers Warn

Cancer Patients Should Avoid Fish, Fish Oil During Chemo, Researchers Warn

Researchers warn patients to temporarily avoid fish oil from the day before chemotherapy until the day thereafter based on research results.

Adding More Dietary Lycopene May Help Protect Against Kidney Cancer

Adding More Dietary Lycopene May Help Protect Against Kidney Cancer

While larger studies are needed, a retrospective analysis indicated a link between lycopene intake and lower risk of developing renal cell carcinoma (RCC).

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs